0000899243-22-014551.txt : 20220412 0000899243-22-014551.hdr.sgml : 20220412 20220412160718 ACCESSION NUMBER: 0000899243-22-014551 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220408 FILED AS OF DATE: 20220412 DATE AS OF CHANGE: 20220412 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Lee Yuchun CENTRAL INDEX KEY: 0001334365 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-19319 FILM NUMBER: 22822351 MAIL ADDRESS: STREET 1: 170 TRACER LA. CITY: WALTHAM STATE: MA ZIP: 02451 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: VERTEX PHARMACEUTICALS INC / MA CENTRAL INDEX KEY: 0000875320 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 043039129 STATE OF INCORPORATION: MA FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 50 NORTHERN AVENUE CITY: BOSTON STATE: MA ZIP: 02210 BUSINESS PHONE: 6173416393 MAIL ADDRESS: STREET 1: 50 NORTHERN AVENUE CITY: BOSTON STATE: MA ZIP: 02210 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2022-04-08 0 0000875320 VERTEX PHARMACEUTICALS INC / MA VRTX 0001334365 Lee Yuchun C/O VERTEX PHARMACEUTICALS INCORPORATED 50 NORTHERN AVENUE BOSTON MA 02210 1 0 0 0 Common Stock 2022-04-08 4 M 0 2000 81.54 A 3875 D Common Stock 2022-04-08 4 S 0 418 276.62 D 3457 D Common Stock 2022-04-08 4 S 0 430 277.29 D 3027 D Common Stock 2022-04-08 4 S 0 700 279.36 D 2327 D Common Stock 2022-04-08 4 S 0 452 280.37 D 1875 D Common Stock 2022-04-11 4 M 0 2000 81.54 A 3875 D Common Stock 2022-04-11 4 S 0 922 279.81 D 2953 D Common Stock 2022-04-11 4 S 0 968 280.62 D 1985 D Common Stock 2022-04-11 4 S 0 110 281.58 D 1875 D Stock Option (Right to Buy) 81.54 2022-04-08 4 M 0 2000 0.00 D 2023-05-31 Common Stock 2000 10000 D Stock Option (Right to Buy) 81.54 2022-04-11 4 M 0 2000 0.00 D 2023-05-31 Common Stock 2000 8000 D Transaction made pursuant to Mr. Lee's company approved trading plan under Rule 10b5-1. Mr. Lee undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. Open market sales reported on this line occurred at a weighted average price of $276.62 (range $276.08 to $276.81). Open market sales reported on this line occurred at a weighted average price of $277.29 (range $277.16 to $277.46). Open market sales reported on this line occurred at a weighted average price of $279.36 (range $278.86 to $279.74). Open market sales reported on this line occurred at a weighted average price of $280.37 (range $280.06 to $281.02). Open market sales reported on this line occurred at a weighted average price of $279.81 (range $279.29 to $280.18). Open market sales reported on this line occurred at a weighted average price of $280.62 (range $280.31 to $281.28). Open market sales reported on this line occurred at a weighted average price of $281.58 (range $281.55 to $281.58). Fully vested. /s/ Sabrina Yohai, Attorney-in-Fact 2022-04-12